Clinical Operations, • 9/19/25 Rare Isn’t Small: Incorporating Operational Excellence into Global, Multisite Rare Disease Trials Previous Patient Recruitment and Engagement in in Global, Multisite Rare Disease Trials Next Optimizing CRO and Vendor Selection - Examples from the Field You Might Also Like What Matters to Payers: Conversations You Should Start During Phase 2 Beyond the Feasibility Survey: Strategic Site Selection to Accelerate Trials and Optimize Resources AI-Driven Patient Identification and Recruitment Patient-Centric Commercialization: Integrating Patient Voices into Market Access Strategies Decentralized by Design: Operationalizing Hybrid Rare Disease Trials
Clinical Operations, • 9/19/25 Rare Isn’t Small: Incorporating Operational Excellence into Global, Multisite Rare Disease Trials Previous Patient Recruitment and Engagement in in Global, Multisite Rare Disease Trials Next Optimizing CRO and Vendor Selection - Examples from the Field You Might Also Like What Matters to Payers: Conversations You Should Start During Phase 2 Beyond the Feasibility Survey: Strategic Site Selection to Accelerate Trials and Optimize Resources AI-Driven Patient Identification and Recruitment Patient-Centric Commercialization: Integrating Patient Voices into Market Access Strategies Decentralized by Design: Operationalizing Hybrid Rare Disease Trials
